FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Insulet's Trailing 12-Month Free Cash Flow is $281 Mil, and Market Cap is $21,880 Mil. Therefore, Insulet's FCF Yield % for today is 1.28%.
The historical rank and industry rank for Insulet's FCF Yield % or its related term are showing as below:
PODD'
s FCF Yield % Range Over the Past 10 Years
Min: -2.88 Med: -0.57 Max: 1.59
Current: 1.28
During the past 13 years, the highest FCF Yield % of Insulet was 1.59%. The lowest was -2.88%. And the median was -0.57%.
PODD's FCF Yield % is ranked better than 64.97% of 865
companies
in the Medical Devices & Instruments industry
Industry Median: -1.53
vs PODD: 1.28
The historical data trend for Insulet's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Insulet's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Insulet's FCF Yield % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Insulet's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Insulet's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Insulet FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Insulet FCF Yield % Related Terms
Thank you for viewing the detailed overview of Insulet's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PODD has been successfully added to your 